The increase in price target by a reputable analyst like Esther Rajavelu from UBS is a strong positive signal for Applied Therapeutics. It suggests confidence in the company's future performance and potential for stock price appreciation. This kind of analyst action typically leads to increased investor interest and can drive the stock price up in the short term.